M. Schlemmer
LMU Klinikum(DE)Krankenhaus Barmherzige Brüder(DE)Ludwig-Maximilians-Universität München(DE)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment, Gastric Cancer Management and Outcomes, Gastrointestinal disorders and treatments, Vascular Tumors and Angiosarcomas
Most-Cited Works
- → One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor(2012)957 cited
- → KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours(2006)894 cited
- → Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800mg after progression on 400mg(2005)373 cited
- → Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A European Organisation for Research and Treatment of Cancer–Italian Sarcoma Group–Australasian Gastrointestinal Trials Group Study(2005)279 cited
- → Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group(2008)234 cited
- → Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial